Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets
Open accessThe DOI matches its Crossref record; 235 of the 237 references it cites were found in a registry or an index.
Abstract
NADPH oxidases are a family of enzymes that generate reactive oxygen species (ROS). The NOX1 (NADPH oxidase 1) and NOX2 oxidases are the major sources of ROS in the artery wall in conditions such as hypertension, hypercholesterolaemia, diabetes and ageing, and so they are important contributors to the oxidative stress, endothelial dysfunction and vascular inflammation that underlies arterial remodelling and atherogenesis. In this Review, we advance the concept that compared to the use of conventional antioxidants, inhibiting NOX1 and NOX2 oxidases is a superior approach for combating oxidative stress. We briefly describe some common and emerging putative NADPH oxidase inhibitors. In addition, we highlight the crucial role of the NADPH oxidase regulatory subunit, p47phox, in the activity of vascular NOX1 and NOX2 oxidases, and suggest how a better understanding of its specific molecular interactions may enable the development of novel isoform-selective drugs to prevent or treat cardiovascular diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
The cited source says what the claim attributes to it.
In the citing paper
“In the human vasculature, the most relevant isoforms appear to be NOX1, NOX2, NOX4, and NOX5 (252, 253, 555).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“NADPH oxidase, a multiunit enzyme particularly enriched in cerebral blood vessels (Miller et al., 2005), has emerges as an important source in vascular oxidative stress in aging, hypertension, hyperlipidemia and diabetes (Faraci, 2011), and inhibition or genetic inactivation of this enzyme has been shown to ameliorate the vascular dysfunction (Drummond et al., 2011).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Drummond et al., 2011
In the citing paper
“NOXs are multiprotein enzyme complexes that catalyze the electron transfer to molecular oxygen to form ROS, more commonly superoxide, but also hydrogen peroxide (79, 252, 383, 546, 912).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
In the citing paper
“The current knowledge about NOX enzymes in the cardiovascular system indicates that NOX2 is usually the main player in the development of pathological conditions and increased NOX2 activity is linked to vascular disease (142, 252, 478).”
From Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation (2019) · cites this paper as [252]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · cited 1×
“As vascular NADPH oxidases, especially NOX2 oxidase, are similar in structure to the phagocytic NADPH oxidase (see below and Ref”
BackgroundNOX enzymes and the biology of reactive oxygen
Lambeth, J. D. (2004) · Nature Reviews Immunology · doi:10.1038/nri1312 · Cited by 3,125 · cited 1×
“NOX2 oxidase in phagocytic cells was the first member of the NADPH oxidase family to be identifie”
BackgroundAngiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells.
Griendling, K. K., Minieri, C. A., Ollerenshaw, J. D., & Alexander, R. W. (1994) · Circulation Research · doi:10.1161/01.res.74.6.1141 · Cited by 2,735
Self-citationRole of Oxidative Modifications in Atherosclerosis
Stocker, R., & Keaney, J. F. (2004) · Physiological Reviews · doi:10.1152/physrev.00047.2003 · Cited by 2,624 · cited 1×
“Oxidative stress not only causes direct and irreversible oxidative damage to macromolecules but also disrupts key redox-dependent signalling processes in the arterial wal”
BackgroundSuperoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor
Gryglewski, R. J., Palmer, R. M. J., & Moncada, S. (1986) · Nature · doi:10.1038/320454a0 · Cited by 2,400 · cited 1×
“This nullifies the anti-inflammatory and vasodilator functions of NO, and promotes the formation of peroxynitrit”
BackgroundPeroxynitrite: biochemistry, pathophysiology and development of therapeutics
Szabó, C., Ischiropoulos, H., & Radi, R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2222 · Cited by 2,134 · cited 1×
“Peroxynitrite is a powerful oxidant in its own right, and may thus contribute to oxidative stress through oxidation of small-molecule antioxidants such as glutathione, cysteine and tetrahydro—biopteri”
BackgroundSegal, A. W. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115653 · Cited by 1,789 · cited 1×
“NOX2 oxidase-expressing leukocytes classically comprise cells of the innate immune system — that is, neutrophils, monocytes and macrophage”
BackgroundRole of the T cell in the genesis of angiotensin II–induced hypertension and vascular dysfunction
Guzik, T. J., Hoch, N. E., Brown, K. A., McCann, L. A., Rahman, A., Dikalov, S., Goronzy, J., Weyand, C., & Harrison, D. G. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070657 · Cited by 1,736 · cited 1×
“NOX2 oxidase activity in circulating T lymphocytes is increased in experimental hypertensio”
BackgroundChronic Granulomatous Disease: Report on a National Registry of 368 Patients
Winkelstein, J. A., Marino, M. C., Johnston, R. B., Boyle, J., Curnutte, J., Gallin, J. I., Malech, H. L., Holland, S. M., Ochs, H., Quie, P., et al. (2000) · Medicine · doi:10.1097/00005792-200005000-00003 · Cited by 1,728
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Research works printed but not linked: 1
- Takac, I. et al. The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4. J. Biol. Chem. 286, 13304–13313 (2011). · DOI · Paper page
Cited by
Items 401–500 of 900
Protein disulfide isomerase and Nox: new partners in redox signaling
Trevelin, S., & Lopes, L. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666151029112523 · Cited by 37
Sghaïer, M. B., Mousslim, M., Pagano, A., Ammari, Y., Luis, J., & Kovacic, H. (2016) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2016.07.019 · Cited by 40
Raghuraman, G., Zuniga, M. C., Yuan, H., & Zhou, W. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.015 · Cited by 42
Histone Methylation and Oxidative Stress in Cardiovascular Diseases
Yi, X., Zhu, Q., Wu, X., Tan, T.-T., & Jiang, X.-J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/6023710 · Cited by 43
“In mammals, the NOX family consists of seven isoforms (NOX1-5 and dual oxidases 1-2 (DUOX1-2)), which are named according to their core catalytic subunits and regulatory subunits, respectively [38].”
Campuzano, V., Puimedon, M. S., Terrado, V., Sánchez‐Rodríguez, C., Coustets, M., Menacho-Márquez, M., Nevado, J., Bustelo, X. R., Francke, U., & Jurado, L. A. P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002458 · Cited by 42
“Apocynin is thought to inhibit NADPH-oxidase assembly by preventing phosphorylation of the autoinhibitory region of p47, along with some scavenger activity of hydrogen peroxide [37].”
BackgroundYamamoto, T., Nakano, H., Shiomi, K., Wanibuchi, K., Masui, H., Takahashi, T., Urano, Y., & Kamata, T. (2017) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00804 · Cited by 37
Spatial Properties of Reactive Oxygen Species Govern Pathogen-Specific Immune System Responses
To, E. E., O’Leary, J. J., O'Neill, L. A. J., Vlahos, R., Bozinovski, S., Porter, C. J. H., Brooks, R. D., Brooks, D. A., & Selemidis, S. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8027 · Cited by 38
“This ROS generation is the primary function of an enzyme family called NADPH oxidases and is distinct from other enzymes that produce ROS either as a by-product of their normal catalytic activity or due to abnormal function during disease (3, 5, 7, 10, 11, 22, 25, 33, 39).”
BackgroundSelf-citationDahan, I. M., & Pick, E. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1007-4 · Cited by 36
Regional Heterogeneity of Cerebral Microvessels and Brain Susceptibility to Oxidative Stress
Austin, S. A., Santhanam, A. V. R., d’Uscio, L. V., & Katušić, Z. S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0144062 · Cited by 36
“These enzymes function to produce superoxide anion while other sources of superoxide anion are simply a by-product or a product produced when proper enzyme activity is impaired [21,22].”
BackgroundPyridine Dinucleotides from Molecules to Man
Fessel, J. P., & Oldham, W. M. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7120 · Cited by 38
“The two DUOX family members DUOX1 and DUOX2 each contain EF-hand domains and also associate with stabilizing/activating subunits DUOXA1 and/or DUOXA2.”
InfluentialLew, W. Y. W., Bayna, E. M., Molle, E. D., Contu, R., Condorelli, G., & Tang, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107556 · Cited by 37
“The development of new therapies to target miRs [35,36] and NOX [48] have emerged as an active area of investigation.”
BackgroundRedox Modulation of FAK Controls Melanoma Survival - Role of NOX4
Ribeiro-Pereira, C., Moraes, J. A., Souza, M. D. J., Laurindo, F. R., Arruda, M. A., & Barja-Fidalgo, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099481 · Cited by 35
“phagocytes, but it is also found in a variety of non-phagocytic cell types, where it is mainly activated in response to agonists [47].”
BackgroundSignaling at the Crossroads: Matrix-Derived Proteoglycan and Reactive Oxygen Species Signaling
Nastase, M.-V., Janicova, A., Wygrecka, M., & Schaefer, L. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7165 · Cited by 37
Impaired Vascular Redox Signaling in the Vascular Complications of Obesity and Diabetes Mellitus
Akoumianakis, I., & Antoniades, C. A. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7421 · Cited by 41
“However, 98 their excessive production in the vasculature is linked to vascular disease (40,112,136,212).”
Metabolic Alterations in Cardiopulmonary Vascular Dysfunction
Smolders, V. F. E. D., Zodda, E., Quax, P. H. A., Carini, M., Barberà, J. A., Thomson, T. M., Tura-Ceide, O., & Cascante, M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2018.00120 · Cited by 37
“These oxidases are multisubunit enzyme complexes that produce superoxide from molecular oxygen and NADPH as electron donor (Drummond et al., 2011).”
Backgroundvan Deventer, C. A., Lindeque, J. Z., van Rensburg, P. J., Malan, L., van der Westhuizen, F. H., & Louw, R. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.11.007 · Cited by 41
Ceron, C. S., Marchi, K. C., Muniz, J. J., & Tirapelli, C. R. (2015) · Current Hypertension Reviews · doi:10.2174/157340211004150319122736 · Cited by 35
“modulation of prostnoids metabolism [72, 73].”
Yin, W., Xu, H., Bai, Z., Wu, Y., Zhang, Y., Liu, R., Wang, Z., Zhang, B., Shen, J., Zhang, H., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55939-2 · Cited by 40
“TargetingNADPHoxidasetoreduceROSproductionisthoughtto be more effective in treating ROS-related vascular disease than non-enzymaticanti-oxidants such asvitamin E 74 .”
Sharma, B., & Singh, N. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.11.011 · Cited by 35
Tanaka, K., Ishihara, T., Sugizaki, T., Kobayashi, D., Yamashita, Y., Tahara, K., Yamakawa, N., Iijima, K., Mogushi, K., Tanaka, H., et al. (2013) · Nature Communications · doi:10.1038/ncomms3686 · Cited by 34
Howitt, L., Kuo, I. Y., Ellis, A., Chaston, D. J., Shin, H., Hansen, P., & Hill, C. E. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt043 · Cited by 41
Lei, X., Li, H., Zhang, J., Zhang, Y., Liu, Y., & Yang, K.-H. (2019) · Ophthalmic Research · doi:10.1159/000499020 · Cited by 36
Chikhale, R. V., Sinha, S. K., Wanjari, M., Gurav, N. S., Ayyanar, M., Prasad, S. K., Khanal, P., Dey, Y. N., Patil, R. B., & Gurav, S. S. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10183-w · Cited by 40
Kim, G. Y., Lim, S., & Kim, K. D. (2021) · Cells · doi:10.3390/cells10102649 · Cited by 36
“NOX5 upregulation by NDRG2 enhances cisplatin‐mediated apoptosis through ROS production.”
BackgroundKotla, S., Singh, N. K., Traylor, J. G., Orr, A. W., & Rao, G. N. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.08.007 · Cited by 35
Neurofibromin-Deficient Myeloid Cells Are Critical Mediators of Aneurysm Formation In Vivo
Li, F., Downing, B., Smiley, L. C., Mund, J. A., Distasi, M. R., Bessler, W., Sarchet, K. N., Hinds, D. M., Kamendulis, L. M., Hingtgen, C. M., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.006320 · Cited by 34
“Apocynin’s dimerized form is believed to inhibit the binding of the p47 cytosolic subunit to the membranebound gp91 subunit, therefore inhibiting the formation of the active NOX2 complex.(44) These studies provide a rationale for transgenic murine studies using cell-specific deletion of p47 and gp91 within endothelial…”
BackgroundSobey, C. G., Judkins, C. P., Rivera, J., Lewis, C. V., Diep, H., Lee, H. W., Kemp-Harper, B. K., Broughton, B. R. S., Selemidis, S., Gaspari, T. A., et al. (2015) · Free Radical Research · doi:10.3109/10715762.2014.992893 · Cited by 33
Self-citationMuhie, S. Y., Gautam, A., Yang, R., Misganaw, B., Daigle, B. J., Mellon, S. H., Flory, J. D., Amara, D. A., Lee, I., Wang, K., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2023.101045 · Cited by 41
“High NADPH oxidase activity in leukocytes may contribute to increased systemic inflammation and early vascular aging.44 Impaired antioxidant activity was indicated by decreased SOD2 expression, lower circulating L-arginine,50 and increased phosphorylation of ERK1/2.44 Mitochondria-derived oxidants can lead to oxidativ…”
InfluentialTian, R., Ding, Y., Peng, Y., & Lu, N. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b00631 · Cited by 33
Ferko, M.-A., & Catelas, I. (2018) · PLoS ONE · doi:10.1371/journal.pone.0199936 · Cited by 35
Wu, W., Li, L., Su, X., Zhu, Z., Lin, X., Zhang, J., Zhuang, Z., Cai, H., & Huang, W. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01464-z · Cited by 33
“Cui Y, Wang Y, Li G, Ma W, Zhou X, Wang J, et al. The Nox1/Nox4 inhibitor attenuates acute lung injury induced by ischemia-reperfusion in mice.”
BackgroundInfluentialGuo, F., Song, W., Jiang, T., Liu, L., Wang, F., Zhong, H., Yin, H., Wang, Q., & Xiong, L. (2014) · Brain Research · doi:10.1016/j.brainres.2014.05.020 · Cited by 33
“Focal cerebral ischemia was induced by MCAO in mice using an intraluminal filament technique as described previously (Hata et al., 1998; Wang et al., 2009).”
MethodZhuge, Z., Haworth, S. M., Nihlén, C., Carvalho, L. R. R. A., Heuser, S. K., Kleschyov, A. L., Nasiell, J., Cortese-Krott, M. M., Weitzberg, E., Lundberg, J. O., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102612 · Cited by 35
H2O2 lowers the cytosolic Ca2+ concentration via activation of cGMP-dependent protein kinase Iα
Müller, P. M., Gnügge, R., Dhayade, S., Thunemann, M., Krippeit‐Drews, P., Drews, G., & Feil, R. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.011 · Cited by 32
“The level of oxidized cGKIa might be much higher in pathophysiological situations associated with increased oxidative stress, such as sepsis, ischemia/reperfusion injury, heart failure, atherosclerosis, endothelial dysfunction, and hypertension [51,52].”
BackgroundRole of T-type channels in vasomotor function: team player or chameleon?
Kuo, I. Y., Howitt, L., Sandow, S. L., McFarlane, A., Hansen, P., & Hill, C. E. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1430-x · Cited by 32
Role of NADPH Oxidase-4 in Human Endothelial Progenitor Cells
Hakami, N., Ranjan, A. K., Hardikar, A. A., Dusting, G. J., & Peshavariya, H. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00150 · Cited by 34
“Each isoform differs in terms of expression, subcellular localization, type of ROS produced and their activation (Chan et al., 2009; Drummond et al., 2011).”
BackgroundTian, R., Peng, R., Yang, Z., Peng, Y., & Lu, N. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.01.007 · Cited by 35
Role of nitroxyl (HNO) in cardiovascular system: From biochemistry to pharmacology
Sun, H., Wu, Z., Cao, L., Zhu, M., Nie, X.-W., Huang, D., Sun, M., & Bian, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104961 · Cited by 36
Kinoshita, H., Matsumura, T., Ishii, N., Fukuda, K., Senokuchi, T., Motoshima, H., Kondo, T., Taketa, K., Kawasaki, S., Hanatani, S., et al. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.01.014 · Cited by 33
“Interestingly, apocynin has been reported to have both NADPH oxidase-dependent and NADPH oxidase-independent anti-oxidative effects [13].”
BackgroundLiu, S., Duan, X., Jin, S., Teng, X., Xiao, L., Xue, H., & Wu, Y. (2016) · American Journal of Hypertension · doi:10.1093/ajh/hpw104 · Cited by 33
Li, Y., Liu, X.-T., Zhang, P., Li, Y., Sun, M., Wang, Y., Wang, S., Yang, H. Q., Liu, B., Wang, M., et al. (2022) · Antioxidants · doi:10.3390/antiox11040728 · Cited by 37
“NOXs are an important source of ROS in cardiovascular diseases [7].”
BackgroundInfluentialScioli, M. G., Bielli, A., Agostinelli, S., Tarquini, C., Arcuri, G., Ferlosio, A., Costanza, G., Doldo, E., & Orlandi, A. (2014) · Journal of Vascular Research · doi:10.1159/000365926 · Cited by 32
Tsai, M.-H., Lee, C., Hsu, L.-F., Li, S.-Y., Chiang, Y., Lee, M., Chen, C., Liang, H., How, J.-M., Chang, P., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.019 · Cited by 32
Treatment with NADPH oxidase inhibitor apocynin alleviates diabetic neuropathic pain in rats
�lker, S., Olukman, M., Önal, A., Çelenk, F. G., Uyanıkgil, Y., Çavuşoğlu, T., & Düzenli̇, N. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.232530 · Cited by 31
“NOXs mediate neuropathic pain processing (Kallenborn-Gerhardt et al., 2013).”
BackgroundInfluentialNOX2 oxidase expressed in endosomes promotes cell proliferation and prostate tumour development
Harrison, I. P., Vinh, A., Johnson, I. R. D., Luong, R., Drummond, G. R., Sobey, C. G., Tiganis, T., Williams, E. D., O’Leary, J. J., Brooks, D. A., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.26237 · Cited by 31
“The NADPH oxidase (NOX) enzymes are a family of oxidases whose sole function is to generate ROS [2, 8, 27], and this appears to have an important role in angiogenesis [32, 28].”
Self-citationThe Role of Antioxidants in the Prevention of Cadmium-Induced Endothelial Dysfunction
Almenara, C. C. P., de Oliveira, T. F., & Padilha, A. S. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200415172338 · Cited by 34
Fan, L. M., Liu, F., Du, J., Geng, L., & Li, J. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102269 · Cited by 37
“In animal models, selective knockout of p47phox or Nox2 can prevent the development of oxidative stress-related vascular diseases which makes Nox2 an attractive target for pharmacological intervention [8,9].”
BackgroundCannizzo, B., Quesada, I., Militello, R. D., Sanchez, C. A., Miatello, R. M., Cruzado, M., & Castro, C. (2014) · Free Radical Research · doi:10.3109/10715762.2014.889295 · Cited by 33
“Endothelial cells express Nox1, Nox2, Nox4, and Nox5; vascular smooth muscle cells express Nox1, Nox4, and Nox5; and adventitial fi broblasts express Nox2 and Nox4 [12].”
BackgroundInfluentialde Faria, C. M. Q. G., Nazaré, A. C., Petrônio, M. S., Paracatu, L. C., Zeraik, M. L., Regasini, L. O., Silva, D. H. S., da Fonseca, L. M., & Ximenes, V. F. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712803341557 · Cited by 37
“For these reasons, specific and potent inhibitors of NADPH oxidase are potential therapeutic agents for the treatment chronic inflammatory disease [14].”
Backgroundvan der Merwe, J. D., de Beer, D., Joubert, E., & Gelderblom, W. C. A. (2015) · Molecules · doi:10.3390/molecules201219868 · Cited by 31
“The role of Ncf2 in the liver is unclear, however, it encodes for a multi-enzyme complex known as NADPH oxidase, which plays an essential role in regulating the activity of neutrophils [29,30].”
BackgroundMechanisms and therapeutic targets of carbon monoxide poisoning: A focus on reactive oxygen species
Wang, T., & Zhang, Y. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111223 · Cited by 34
Design, synthesis, and biological evaluation of inhibitors of the NADPH oxidase, Nox4
Xu, Q., Kulkarni, A. A., Sajith, A. M., Hussein, D., Brown, D., Güner, O. F., Motati, D. R., Watkins, E. B., Lassegue, B. P., Griendling, K. K., et al. (2017) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2017.12.023 · Cited by 32
Self-citationCardiovascular Complications in Hematopoietic Stem Cell Transplanted Patients
Zhao, Y. H., He, R., Oerther, S., Zhou, W., Vosough, M., & Hassan, M. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12111797 · Cited by 32
“In addition, oxidative stress and increased vascular superoxide production are associated with endothelial dysfunction via an ROS-induced alternation in endothelial signal transduction and redox-regulated transcription factors [94,95].”
BackgroundOxidative Stress, Neuroinflammation, and Neurodegeneration
Gao, H., Zhou, H., & Hong, J. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1071-7_5 · Cited by 38
“The limitation of known NOX2 inhibitors, the prooxidant potential of apocynin, the insuffi cient specifi city and high toxicity of DPI, the irreversible off-target effect on serine proteases and low effi cacy with an IC50 greater than 1 mM of AEBSF (4-(2-aminoethyl)benzenesulfonyl fl uoride hydrochloride), and unfavor…”
BackgroundRegulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents
Maiocchi, S. L., Morris, J. C., Rees, M. D., & Thomas, S. R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.03.016 · Cited by 33
“Apocynin (phenolic) Inhibits NADPH oxidase activity [56], improves NO”
BackgroundScioli, M. G., Lo Giudice, P., Bielli, A., Tarallo, V., De Rosa, A., De Falco, S., & Orlandi, A. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140697 · Cited by 29
“To verify if Nox4 activity was responsible for oxidative stress in serum-deprived HMVECs, we used the specific Nox4 inhibitor plumbagin [38] and siRNA for Nox4 (siNox4).”
MethodOxyradical Stress, Endocannabinoids, and Atherosclerosis
Matthews, A. T., & Ross, M. K. (2015) · Toxics · doi:10.3390/toxics3040481 · Cited by 30
“This finding supports the notion that pharmacological inhibition of Nox might be an attractive strategy to reduce atherosclerosis [15].”
BackgroundKleikers, P. W., Hooijmans, C., Göb, E., Langhauser, F., Rewell, S. S., Radermacher, K., Ritskes-Hoitinga, M., Howells, D. W., Kleinschnitz, C., & HHW Schmidt, H. (2015) · Scientific Reports · doi:10.1038/srep13428 · Cited by 29
Emrich, F. C., Penov, K., Arakawa, M., Dhablania, N., Burdon, G., Pedroza, A. J., Koyano, T. K., Kim, Y. M., Raaz, U., Connolly, A. J., et al. (2019) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14587 · Cited by 30
NADPH Oxidase Overactivity Underlies Telomere Shortening in Human Atherosclerosis
Pejenaute, Á., Cortés, A., Marqués, J., Montero, L., Beloqui, Ó., Fortuño, A., Martí, A., Orbe, J., & Zalba, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041434 · Cited by 30
“The NADPH oxidase family represents the most important vascular source of reactive oxygen species (ROS), mainly superoxide and hydrogen peroxide, which are present in endothelial cells, smooth muscle cells, fibroblasts, and infiltrated monocytes/macrophages [6,7].”
BackgroundThe role of dual oxidases in physiology and cancer
de Faria, C. C., & Fortunato, R. S. (2020) · Genetics and Molecular Biology · doi:10.1590/1678-4685/gmb-2019-0096 · Cited by 34
“Unlike the isoforms 1-4, NOX5 and DUOX 1 and 2 have an intracellular calcium-binding site that is closely related to their activation (Drummond et al., 2011).”
BackgroundOxidative Stress-Related Susceptibility to Aneurysm in Marfan’s Syndrome
Rysz, J., Gluba-Brzózka, A., Rokicki, R., & Franczyk, B. (2021) · Biomedicines · doi:10.3390/biomedicines9091171 · Cited by 30
An Activatable NIR‐II Nanoprobe for In Vivo Early Real‐Time Diagnosis of Traumatic Brain Injury
Li, C., Li, W., Liu, H., Zhang, Y., Chen, G., Li, Z., & Wang, Q. (2019) · Angewandte Chemie · doi:10.1002/ange.201911803 · Cited by 29
Redox regulation of vascular remodeling
Galougahi, K. K., Ashley, E. A., & Ali, Z. A. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-2068-y · Cited by 31
“The activity and expression of Nox can be regulated by cytokines [tumor necrosis factor-a (TNFa, transforming growth factor b (TGFb), platelet-derived growth factor (PDGF)] and agonists like angiotensin II (AngII) and thrombin [18].”
Engineered silica nanocarriers as a high-payload delivery vehicle for antioxidant enzymes
Ambati, J., Lopez, A. M., Cochran, D. B., Wattamwar, P. P., Bean, K., Dziubla, T. D., & Rankin, S. E. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.02.012 · Cited by 30
Liu, Y., Hernández‐Ochoa, E. O., Randall, W. R., & Schneider, M. F. (2012) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00152.2012 · Cited by 34
“Direct Ca(2) activation of NOX2 does not seem to occur (5, 8), but Ca(2) binding to some other direct or indirect regulator of NOX2 might be a possibility.”
BackgroundThe Role of Uridine Adenosine Tetraphosphate in the Vascular System
Matsumoto, T., Tostes, R. C., & Webb, R. C. (2011) · Advances in Pharmacological Sciences · doi:10.1155/2011/435132 · Cited by 29
Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases
Zielonka, J., Hardy, M., Michalski, R., Sikora, A., Zielonka, M., Cheng, G., Ouari, O., Podsiadły, R., & Kalyanaraman, B. (2017) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-017-0813-6 · Cited by 29
Magyar, K., Deres, L., Erős, K., Bruszt, K., Seress, L., Hamar, J., Hideg, K., Balogh, A., Gallyas, F., Sümegi, B., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.03.008 · Cited by 33
“Therefore, attenuating oxidative stress, or inhibiting these pathways may present an alternative way to protect the vasculature from hypertension induced damages [5,14].”
InfluentialWanschel, A. C. B. A., Guizoni, D. M., Lorza‐Gil, E., Salerno, A. G., Paiva, A. A., Dorighello, G. G., Davel, A. P., Balkan, W., Hare, J. M., & Oliveira, H. C. F. (2021) · Biomolecules · doi:10.3390/biom11010069 · Cited by 29
“Although several isoforms of NOX are expressed in the vessel endothelium, accumulating evidence suggests a crucial role of NOX2 in endothelial injury [34].”
BackgroundBigagli, E., Raimondi, L., Mannucci, E., Colombi, C., Bardini, G., Rotella, C. M., & Lodovici, M. (2012) · The British Journal of Diabetes · doi:10.1177/1474651411435588 · Cited by 28
Biomarkers of Oxidative Stress in Vascular Dementia Patients
Shi, G., Liu, C., Wang, L., Guan, L.-P., & Li, S.-Q. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100012701 · Cited by 28
“Extensive evidence supports a role for free radical generation and oxidative injury in the pathogenesis of stroke and other vascular disease 6,7 .”
BackgroundZhou, Z., Yin, Y., Chang, Q., Sun, G., Lin, J., & Dai, Y. (2016) · Cell Proliferation · doi:10.1111/cpr.12319 · Cited by 35
Lajko, M., Cardona, H. J., Taylor, J. M., Shah, R. S., Farrow, K. N., & Fawzi, A. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166886 · Cited by 29
Amos, D., Cook, C. R., & Santanam, N. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.01.002 · Cited by 30
NOX2β: A Novel Splice Variant of NOX2 That Regulates NADPH Oxidase Activity in Macrophages
Harrison, C. B., Selemidis, S., Guida, E., King, P. T., Sobey, C. G., & Drummond, G. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048326 · Cited by 30
“Furthermore, excessive Nox2 oxidase activity is an important contributor to the oxidative stress and tissue pathologies of several chronic diseases such as hypertension, diabetes and atherosclerosis [26,27].”
BackgroundSelf-citationBernard, A., Ku, J., Vlahos, R., & Miller, A. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-51728-2 · Cited by 29
Mild Cognitive Impairment and Donepezil Impact Mitochondrial Respiratory Capacity in Skeletal Muscle
Morris, J. K., McCoin, C. S., Fuller, K. N. Z., John, C. S., Wilkins, H., Green, Z. D., Wang, X., Sharma, P., Burns, J. M., Vidoni, E. D., et al. (2021) · Function · doi:10.1093/function/zqab045 · Cited by 28
Cross-Talk of NADPH Oxidases and Inflammation in Obesity
Morawietz, H., Brendel, H., Diaba‐Nuhoho, P., Catar, R. A., Perakakis, N., Wolfrum, C., & Bornstein, S. R. (2023) · Antioxidants · doi:10.3390/antiox12081589 · Cited by 30
Oxidative stress, NADPH oxidases, and arteries
Sun, Q.-A., Madamanchi, N. R., & Runge, M. S. (2015) · Hämostaseologie · doi:10.5482/hamo-14-11-0076 · Cited by 29
“Peroxynitrite, a potent oxidant itself, can oxidize small-molecule antioxidants such as glutathione and tetrahydrobiopterin (14, 15).”
Aleliunas, R. E., Aljaadi, A. M., Laher, I., Glier, M. B., Green, T., Murphy, M. A., Miller, J. W., & Devlin, A. M. (2016) · Journal of Nutrition · doi:10.3945/jn.115.227629 · Cited by 29
Kotla, S., & Rao, G. N. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686865 · Cited by 28
“Anti-phosphotyrosine antibodies (05-777) and p300 immunoprecipitation-HAT assay kit (17-284) were purchased from Millipore Corp.”
BackgroundMethodRetractedHort, J., Vališ, M., Kuča, K., & Angelucci, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102405 · Cited by 29
“ROS derived from the enzyme NADPH oxidase are key pathogenic effectors of cerebrovascular dysregulation [63].”
BackgroundHowitt, L., Chaston, D. J., Sandow, S. L., Matthaei, K. I., Edwards, F., & Hill, C. E. (2013) · The Journal of Physiology · doi:10.1113/jphysiol.2013.250928 · Cited by 25
“…the increased contribution of T-type channels in Cx40ko mice Angiotensin II is a major activator of NADPH oxidase, upregulation of which is now considered to be responsible for the increased oxidative stress associated with cardiovascular disease (Chrissobolis et al. 2011; Drummond et al. 2011).”
BackgroundGan, X., Su, G., Zhao, W., Huang, P., Luo, G., & Hei, Z. (2013) · Mediators of Inflammation · doi:10.1155/2013/378703 · Cited by 27
Nitroxyl (HNO) suppresses vascular Nox2 oxidase activity
Miller, A. A., Maxwell, K. F., Chrissobolis, S., Bullen, M. L., Ku, J., Silva, T. M. D., Selemidis, S., Hooker, E. U., Drummond, G. R., Sobey, C. G., et al. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.025 · Cited by 26
“In blood vessels, at least four isoforms of NADPH oxidase are expressed, namely Nox1, Nox2, Nox4, and Nox5 [1,2].”
BackgroundInfluentialSelf-citationTuo, Y.-H., Liu, Z., Chen, J., Wang, Q.-Y., Li, S., Li, M., Dai, G., Wang, J., Zhang, Y., Feng, L., et al. (2016) · Journal of NeuroInterventional Surgery · doi:10.1136/neurintsurg-2016-012377 · Cited by 26
PDIA1 acts as master organizer of NOX1/NOX4 balance and phenotype response in vascular smooth muscle
Fernandes, D. C., Wosniak, J., Gonçalves, R. C., Tanaka, L. Y., Fernandes, C. G., Zanatta, D. B., de Mattos, A. B. M., Strauss, B. E., & Laurindo, F. R. M. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.11.020 · Cited by 27
Мозес, В. Г., Korotkevich, O., Анатольевна, Ю. М., Ивановна, Е. С., Владимировна, Р. Е., Борисовна, М. К., & Евгеньевна, П. Т. (2025) · Matʹ i ditâ v Kuzbasse · doi:10.24412/2686-7338-2025-2-61-64 · Cited by 26
Neuropathies and neurological dysfunction induced by coronaviruses
Gholami, M., Safari, S., Ulloa, L., & Motaghinejad, M. (2021) · Journal of NeuroVirology · doi:10.1007/s13365-021-00977-x · Cited by 25
Tasinov, O., Dincheva, I. N., Badjakov, I. K., Kiselova-Kaneva, Y. D., Galunska, B. T., Nogueiras, R., & Ivanova, D. G. (2021) · Plants · doi:10.3390/plants10112446 · Cited by 28
“NOX is among the newly established target molecules in the treatment of hypertension and atherosclerosis, and concomitant pathologies such as diabetes and cardiovascular diseases [91,95].”
BackgroundLi, X., Wan, C.-Q., & Mao, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.979959 · Cited by 27
Song, Z., Zhu, X., Jin, R., Wang, C., Yan, J., Zheng, Q., Nanda, A., Granger, D. N., & Li, G. (2014) · PLoS ONE · doi:10.1371/journal.pone.0101671 · Cited by 26
Wang, G., Chen, Q.-Y., Li, W., Lu, X.-H., & Zhao, X. (2015) · Croatian Medical Journal · doi:10.3325/cmj.2015.56.4 · Cited by 27
Hu, X., Huang, X., Xiao, D., & Zhang, L. (2015) · The Journal of Physiology · doi:10.1113/jp271626 · Cited by 26
“The NADPH oxidase (Nox) family is of critical importance in the regulation of ROS production (Drummond et al. 2011).”
BackgroundAguado, A., Fischer, T., Rodríguez, C., Manea, A., Martínez‐González, J., Touyz, R. M., Hernanz, R., Alonso, M. J., Dixon, D. A., Briones, A. M., et al. (2015) · Journal of Hypertension · doi:10.1097/hjh.0000000000000801 · Cited by 27
“Seven NADPH oxidase isoforms have been identified in mammals, each containing a catalytic subunit called NOX (NOX-1–5) or DUOX (DUOX-1/2) and various regulatory subunits [1].”
BackgroundInfluentialFernandes, D. C., Gonçalves, R. C., & Laurindo, F. R. M. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-6625-7_19 · Cited by 28
GPER blockers as Nox downregulators: A new drug class to target chronic non-communicable diseases
Meyer, M. R., & Barton, M. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.03.019 · Cited by 28
Effect of β-amyloid on blood-brain barrier properties and function
Petrushanko, I. Y., Mitkevich, V. A., & Makarov, A. А. (2023) · Biophysical Reviews · doi:10.1007/s12551-023-01052-x · Cited by 29
Fu, R., Wang, Q., Guo, Q., Xu, J., & Wu, X. (2012) · Vascular Pharmacology · doi:10.1016/j.vph.2012.08.004 · Cited by 25
Metadata
- Authors
- Drummond, G. R., Selemidis, S., Griendling, K. K., & Sobey, C. G.
- Affiliations
- Monash University (AU)
- Emory University (US)
- Corresponding author
- Drummond, Grant R.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2011-06
- Volume
- 10
- Issue
- 6
- Pages
- 453-471
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- PMC
- PMC3361719
- OpenAlex
- W1974997758
- Cited by
- 899
- References
- 237
- Citations by year
- 2026: 25 · 2025: 25 · 2024: 38 · 2023: 35 · 2022: 51 · 2021: 66 · 2020: 69 · 2019: 55 · 2018: 63 · 2017: 77 · 2016: 69 · 2015: 71 · 2014: 83 · 2013: 88 · 2012: 71
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RMIT Research Repository (RMIT University Library) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Heart, Lung, and Blood Institute (HL38206, R01HL038206, HL095070, HL058863, R37HL038206, HL-092120, R01HL092120, P01HL095070, R01HL058863)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- NADPH oxidase, NOX1, NOX2, oxidative stress, reactive oxygen species, NADPH oxidase inhibitors, p47phox, endothelial dysfunction, vascular inflammation, atherogenesis, arterial remodeling, hypertension, hypercholesterolemia, diabetes mellitus, aging, cardiovascular disease
- MeSH terms
- NADPH Oxidase 1, NADPH Oxidase 2, Animals, Antioxidants, Humans, Membrane Glycoproteins, NADH, NADPH Oxidoreductases, Vascular Diseases, Drug Delivery Systems, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.